EyePoint Pharmaceuticals, Inc. (EYPT) is a publicly traded company in the Unknown sector. Across all available filings, 26 corporate insiders have executed 311 transactions totaling $189.7M, demonstrating a bullish sentiment with $33.1M in net insider flow. The most recent transaction on Jan 5, 2026 involved a transaction of 29,250 shares valued at $0.
No significant insider buying has been recorded for EYPT in the recent period.
No significant insider selling has been recorded for EYPT in the recent period.
Based on recent SEC filings, insider sentiment for EYPT is bullish with an Insider Alignment Score of 59/100 and a net flow of $33.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at EyePoint Pharmaceuticals, Inc. (EYPT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 26 insiders are actively trading EYPT stock, having executed 311 transactions in the past 90 days. The most active insider is Ye Liu (Executive), who has made 4 transactions totaling $56.7M.
Get notified when executives and directors at EYPT file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | Ribeiro Ramiro | Chief Medical Officer | Option Exercise | 29,250 | $N/A | $0 | |
| Jan 5, 2026 | Ribeiro Ramiro | Chief Medical Officer | Sale | 42,544 | $17.10 | $727.3K | Large |
| Jan 5, 2026 | Ribeiro Ramiro | Chief Medical Officer | Option Exercise | 29,250 | $8.26 | $241.6K | |
| Jan 2, 2026 | J. Sanders Reginald | Executive | Award | 40,000 | $N/A | $0 | |
| Jan 2, 2026 | L. Zaderej Karen | Executive | Award | 40,000 | $N/A | $0 | |
| Dec 19, 2025 | Elston George | Executive | Gift | 5,000 | $N/A | $0 | |
| Dec 19, 2025 | Elston George | Executive | Gift | 5,000 | $N/A | $0 | |
| Dec 4, 2025 | Lurker Nancy | Executive | Sale | 9,300 | $15.11 | $140.5K | |
| Dec 4, 2025 | Management, Lp Cormorant Asset | Executive | Sale | 60,000 | $15.70 | $942.0K | Large |
| Nov 28, 2025 | Lurker Nancy | Executive | Sale | 500 | $14.95 | $7.5K | |
| Nov 26, 2025 | Lurker Nancy | Executive | Sale | 200 | $14.95 | $3.0K | |
| Nov 11, 2025 | Ribeiro Ramiro | Executive | Sale | 2,722 | $11.61 | $31.6K | |
| Sep 19, 2025 | Elston George | Executive | Gift | 20,000 | $N/A | $0 | |
| Sep 19, 2025 | Elston George | Executive | Gift | 20,000 | $N/A | $0 | |
| Jul 11, 2025 | L. Zaderej Karen | Executive | Option Exercise | 2,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 40 | $111.4M | 50.5% |
Sale(S) | 61 | $78.3M | 35.5% |
Conversion(C) | 2 | $24.1M | 10.9% |
Exercise(M) | 137 | $3.8M | 1.7% |
Payment(F) | 54 | $2.9M | 1.3% |
Award(A) | 5 | $0 | 0.0% |
Gift(G) | 12 | $0 | 0.0% |
Insider activity at EyePoint Pharmaceuticals, Inc. shows mixed signals across all time. While $111.4M in purchases indicates some executive confidence,$78.3M in sales balances the picture, resulting in a modest net flow of $33.1M.26 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Ye Liu, has transacted $56.7M during this period.